The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death
Clinical trial NCT00568737 · COMPLETED
Trial details
- NCT number
- NCT00568737
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 2640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.